Natural product-like synthetic libraries.

There is a paucity of chemical matter suitably poised for effective drug development. Improving the quality and efficiency of research early on in the drug discovery process has been a long standing objective for the drug industry and improvements to the accessibility and quality of compound screening decks might have a significant and positive impact. In the absence of specific molecular information that can be modeled and used predicatively we are far from identifying which small molecules are most relevant to emerging biological targets such as protein-protein interactions. Natural products have been historically successful as an entry point for drug discovery and recently screening libraries are being synthesized to emulate natural product like features.

[1]  A. Kozikowski,et al.  Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity. , 2006, Journal of medicinal chemistry.

[2]  Nathan T. Ross,et al.  An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. , 2010, Journal of the American Chemical Society.

[3]  Derek S. Tan,et al.  Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. , 2010, Current opinion in chemical biology.

[4]  Stuart L. Schreiber,et al.  Stereochemical and Skeletal Diversity Arising from Amino Propargylic Alcohols , 2010, Organic letters.

[5]  Douglas A. Horton,et al.  The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures , 2003 .

[6]  P. Clemons,et al.  Distinct Biological Network Properties between the Targets of Natural Products and Disease Genes , 2010, Journal of the American Chemical Society.

[7]  Atul Kumar,et al.  Natural product inspired diversity oriented synthesis of tetrahydroquinoline scaffolds as antitubercular agent. , 2011, ACS combinatorial science.

[8]  Matthew E Welsch,et al.  Privileged scaffolds for library design and drug discovery. , 2010, Current opinion in chemical biology.

[9]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[10]  Stuart L Schreiber,et al.  Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog. , 2009, Bioorganic & medicinal chemistry letters.

[11]  Stuart L Schreiber,et al.  A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.

[12]  Sheo B. Singh,et al.  Chapter 2:Chemical Space and the Difference Between Natural Products and Synthetics , 2009 .

[13]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[14]  L. A. Marcaurelle,et al.  Application of natural product-inspired diversity-oriented synthesis to drug discovery. , 2008, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[15]  Bernd Becker,et al.  Biological diversity from a structurally diverse library: systematically scanning conformational space using a pyranose scaffold. , 2010, Journal of Medicinal Chemistry.

[16]  G. Rishton,et al.  Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening. , 2008, Current opinion in chemical biology.

[17]  Daniel Yohannes,et al.  Diversity-oriented synthesis of a cytisine-inspired pyridone library leading to the discovery of novel inhibitors of Bcl-2. , 2009, Bioorganic & Medicinal Chemistry Letters.

[18]  H. Waldmann,et al.  Synthesis of Natural Product Inspired Compound Collections , 2009 .

[19]  Adam Nelson,et al.  Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds** , 2008, Angewandte Chemie.

[20]  Miklos Feher,et al.  Property Distributions: Differences Between Drugs, Natural Products, and Molecules from Combinatorial Chemistry. , 2003 .

[21]  Ricardo Macarron,et al.  Enhancements of screening collections to address areas of unmet medical need: an industry perspective. , 2010, Current opinion in chemical biology.

[22]  Stuart L Schreiber,et al.  A synthesis strategy yielding skeletally diverse small molecules combinatorially. , 2004, Journal of the American Chemical Society.

[23]  Heidi Ledford,et al.  Complex synthesis yields breast-cancer therapy , 2010, Nature.

[24]  N. Nakahata,et al.  Furanodictine A and B: amino sugar analogues produced by cellular slime mold Dictyostelium discoideum showing neuronal differentiation activity. , 2001, The Journal of organic chemistry.

[25]  Derek S. Tan,et al.  The tert-butylsulfinamide lynchpin in transition-metal-mediated multiscaffold library synthesis. , 2010, Organic letters.

[26]  Atul Kumar,et al.  Diversity oriented synthesis of benzoxanthene and benzochromene libraries via one-pot, three-component reactions and their anti-proliferative activity. , 2010, Journal of combinatorial chemistry.

[27]  R. Andersen,et al.  Synthetic analogues of the microtubule-stabilizing sponge alkaloid ceratamine A are more active than the natural product. , 2010, Journal of medicinal chemistry.

[28]  Stephen P. Hale,et al.  The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.

[29]  Zoya Titarenko,et al.  BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery , 2010, Molecular Diversity.

[30]  Youhong Hu,et al.  Three-component one-pot approach to synthesize benzopyrano[4,3-d]pyrimidines. , 2010, Journal of combinatorial chemistry.

[31]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[32]  Herbert Waldmann,et al.  Principles, implementation, and application of biology-oriented synthesis (BIOS) , 2010, Biological chemistry.

[33]  Warren R. J. D. Galloway,et al.  Drug discovery: A question of library design , 2011, Nature.

[34]  E. Jacoby,et al.  Chemogenomic strategies to expand the bioactive chemical space. , 2009, Current medicinal chemistry.

[35]  Daniel Yohannes,et al.  Diversity-oriented synthesis of a cytisine-inspired pyridone library leading to the discovery of novel inhibitors of Bcl-2. , 2009, Bioorganic & medicinal chemistry letters.

[36]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[37]  S. Danishefsky,et al.  Small molecule natural products in the discovery of therapeutic agents: the synthesis connection. , 2006, The Journal of organic chemistry.

[38]  Sivaraman Dandapani,et al.  Current strategies for diversity-oriented synthesis. , 2010, Current opinion in chemical biology.

[39]  Stephen Hanessian,et al.  Total synthesis of natural products, the "Chiron" approach , 1983 .

[40]  J. Porco,et al.  An approach to skeletal diversity using functional group pairing of multifunctional scaffolds. , 2007, Organic letters.

[41]  Paul A. Wender,et al.  Function‐Oriented Synthesis, Step Economy, and Drug Design , 2008 .

[42]  T. Usui,et al.  Novel and facile synthesis of furanodictines A and B based on transformation of 2-acetamido-2-deoxy-D-glucose into 3,6-anhydro hexofuranoses. , 2010, Carbohydrate research.

[43]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[44]  Sangmi Oh,et al.  Construction of a polyheterocyclic benzopyran library with diverse core skeletons through diversity-oriented synthesis pathway. , 2010, Journal of combinatorial chemistry.